Madalina Uzunov

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Real-world patterns of treatment intensity and prognostic model performance in older acute myeloid leukemia: insights from the French ALFA-PPP Cohort.

Real-world patterns of treatment intensity and prognostic model performance in older acute myeloid leukemia: insights from the French ALFA-PPP Cohort.

Journal: Leukemia

Published: April 14, 2026

Early serum S100β but not neuron-specific enolase reflects baseline CNS vulnerability in ICANS after CD19 CAR T-cell therapy.

Early serum S100β but not neuron-specific enolase reflects baseline CNS vulnerability in ICANS after CD19 CAR T-cell therapy.

Journal: Journal of neurology

Published: January 05, 2026

Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

Journal: Leukemia

Published: August 25, 2025

Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.

Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.

Journal: Leukemia

Published: August 25, 2025

Preliminary evidence of CAR T-cell therapy activity in vitreoretinal lymphomas: An LOC network study.

Preliminary evidence of CAR T-cell therapy activity in vitreoretinal lymphomas: An LOC network study.

Journal: HemaSphere

Published: April 20, 2025

Neurotoxicity in Patients With CNS Lymphomas Treated With CAR T-Cell Therapy: A Study From the French Oculo-Cerebral Lymphoma Network.

Neurotoxicity in Patients With CNS Lymphomas Treated With CAR T-Cell Therapy: A Study From the French Oculo-Cerebral Lymphoma Network.

Journal: Neurology

Published: March 27, 2025

Tandem combination of ASCT and CAR T-cell therapy in highly refractory CNS lymphomas.

Tandem combination of ASCT and CAR T-cell therapy in highly refractory CNS lymphomas.

Journal: British journal of haematology

Published: February 05, 2025

BCR::ABL1 Tyrosine Kinase Inhibitors During Pregnancy, a Disproportionality Analysis of Vigibase.

BCR::ABL1 Tyrosine Kinase Inhibitors During Pregnancy, a Disproportionality Analysis of Vigibase.

Journal: Clinical pharmacology and therapeutics

Published: December 04, 2024

ICE polychemotherapy is an efficient salvage treatment in primary central nervous system lymphoma: an LOC network study.

ICE polychemotherapy is an efficient salvage treatment in primary central nervous system lymphoma: an LOC network study.

Journal: Blood advances

Published: July 29, 2024

Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational study.

Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational study.

Journal: British journal of haematology

Published: May 02, 2024

CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network.

CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network.

Journal: American journal of hematology

Published: November 27, 2023

Acute myeloid leukemia with misleading cytology.

Acute myeloid leukemia with misleading cytology.

Journal: International journal of laboratory hematology

Published: October 30, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026